NSE filing, NSE: CAPITALSFB. Summary written from the filing by ALFA Finder's alert engine.
Capital Small Finance Bank Ltd: key numbers
- Share price
- ₹264.00
- Market cap
- ₹1,201 Cr
- Revenue (annual)
- ₹1,049 Cr
- Net profit (annual)
- ₹141.4 Cr
- P/E (TTM)
- 8.0×Sector 19.7×
- Promoter holding
- 18.29%+0.00% QoQ
- FII holding
- 3.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capital Small Finance Bank Ltd
All →Capital Small Finance Bank Investor Presentation: Key Takeaways
Q2FY27 PAT Rs46 Cr (+31% YoY), NII +24%, advances Rs9,755 Cr (+23% YoY), GNPA 2.36%. Vision 2029 targets 2x advances and 1.5x branches.
Capital Small Finance Bank Management Change
Capital Small Finance Bank's board approved two independent director appointments pending shareholder approval. Joseph D'souza is regularised and Nageswara Rao Yalamanchili reappointed.
- Execution
- Joseph Conrad Agnelo D'souza: 5 years from September 28, 2026. Nageswara Rao Yalamanchili: 3 consecutive years from June 29, 2027.
Capital Small Finance Bank Q2 FY27 Results: Net Profit ₹45.6 Cr, Up 30.7% YoY
Capital Small Finance Bank Ltd reported revenue from operations of ₹300.8 Cr (+17.3% YoY) and net profit of ₹45.6 Cr (+30.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹45.6 Cr · +30.7% YoY
Capital Small Finance Bank Employee Stock Options
Capital SFB's NRC approved vesting of 3,71,400 ESOP options (60% of outstanding) to employees. Vested options are exercisable within one year from vesting date.
Capital Small Finance Bank Board Meeting Date
Capital Small Finance Bank meets 29 October 2026 to consider September results, Tier II bonds and ESOP changes. Trading window closes 31 October.
Capital Small Finance Bank Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Other results update announcements
All →Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q2FY27 revenue of Rs. 6,820 Mn (up 16.0% YoY) and PAT of Rs. 1,968 Mn in a press release. Investors see record EBITDA margins of 41.8% and capex progress at Solapur and Taloja.
Asset Reconstruction Company (India) Results Update
ARCIL's H1FY27 release shows total income up 48% to Rs.516.4 crore and PAT up 54% to Rs.290.0 crore. Investors should view performance over a longer horizon.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.
Fiberweb (India) Results Update
Fiberweb India's Q2 FY27 press release shows total income of ₹30.99 crore, up 209.36% quarter-on-quarter. Net profit rose to ₹1.27 crore.
ICRA Results Update
ICRA reported Q2 FY2027 consolidated revenue up 30.2% to Rs 177.9 crore and PAT up 9.2%. Half-year revenue rose 30.7% and PAT rose 20.0%.